00000000nam 22000008i 4500
0019.903160
003CaOODSP
00520250218135235
006m     o  d f      
007cr |||||||||||
008210909t20212021oncd    ob   f000 0 eng d
020 |a9780660402819
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-293/2021E-PDF
24500|aNational report : |bfindings from the Survey on the Impact of COVID-19 on the delivery of STBBI prevention, testing and treatment including harm reduction services in Canada.
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2021.
264 4|c©2021
300 |a1 online resource (19 pages) : |bgraphs
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |a"Publication date: Dec 2021."
500 |aIssued also in HTML format.
500 |aIssued also in French under title: Rapport national : Résultats de l’Enquête concernant l’incidence de la COVID-19 sur la prestation des services de prévention, de dépistage ou de traitement des ITSS, y compris des services de réduction des méfaits au Canada.
504 |aIncludes bibliographical references (pages 18-19).
520 |a"Since the start of the COVID-19 pandemic, unprecedented challenges in delivering primary health care including sexually transmitted and blood-borne infections (STBBI) prevention, testing and treatment services as well as harm reduction services, have been reported across the country. These disruptions may have had a greater impact on populations that are more at risk for STBBI and COVID-19, such as African, Caribbean and Black (ACB) people, Indigenous Peoples and people who use drugs living in Canada (3). The Public Health Agency of Canada (PHAC) developed four national online surveys to better understand the impact of the COVID-19 pandemic on access to and delivery of STBBI prevention, testing, treatment, and harm reduction services, specifically for priority populations"--Introduction, page 1.
650 0|aSexually transmitted diseases|zCanada|xPrevention.
650 0|aBloodborne infections|zCanada|xPrevention.
650 0|aCOVID-19 (Disease)|zCanada.
650 0|aCOVID-19 Pandemic, 2020-2023|xHealth aspects|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tRapport national : |w(CaOODSP)9.903159
85640|qPDF|s741 KB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-293-2021-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/diseases-conditions/survey-impact-covid-19-delivery-stbbi-prevention-testing-treatment.html